MedPath

URISPAS TAB 200MG

URISPAS TAB 200MG

Discontinued
DIN Number

00612332

Drug Class

Human

Market Date

Dec 31, 1986

Company
HC

cedona pharmaceuticals b.v.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00612332
AIG Number0115677001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04BD02 FLAVOXATE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification86:12.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLAVOXATE HYDROCHLORIDEActive
Strength: 200 MG
Monograph: FLAVOXATE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.